Endocrinologia Japonica
Online ISSN : 2185-6370
Print ISSN : 0013-7219
ISSN-L : 0013-7219
Effect of Prostaglandin E1 on Renin and Aldosterone in Hypertensive Patients
MANABU YOSHIMURAHAKUO TAKAHASHIRYOSAKU TAKASHINAYOSHIHIRO KAJITATADAYOSHI MIYAZAKITAKASHI HACHIYAHAMAO IJICHIYUKIO OCHI
Author information
JOURNAL FREE ACCESS

1979 Volume 26 Issue 4 Pages 481-486

Details
Abstract
The effect of prostaglandin E1 (PGE1) on plasma renin activity (PRA) and plasma aldosterone concentration (PAC) was studied in the hypertensive subjects treated with without75mg indomethacin or60mg propranolol for a week. Subsequent to the treatment with indomethacin for a week, PRA and PAC levels were decreased as compared to the control, without changes in the blood pressure and heart rate. During the infusion of PGE1, the blood pressure was decreased and the pulse rate was increased. PRA and PAC levels were also elevated. These changes of parameters were not different between the control and the indomethacin-treated subjects. PRA and PAC were suppressed after the treatment with propranolol. With the infusion of PGE1, the level of PRA was not significantly elevated, while, PAC was significantly increased by the infusion of100ng/Kg/min of PGE1. During the infusion of PGE1, the blood pressure was decreased while the pulse rate was increased in the subjects treated with propranolol. However, the elevation of the pulse rate was less remarkable than the control. These data indicate that PGE, have important roles in the regulation of the release of renin and aldosterone. These findings also suggest that PGE1may act to stimulate the secretion of aldosterone in man.
Content from these authors
© The Japan Endocrine Society
Previous article Next article
feedback
Top